Iron nanoparticles increase 7-ketocholesterol-induced cell death, inflammation, and oxidation on murine cardiac HL1-NB cells

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 185-195

  Kahn, Edmond ^a   Baarine, Mauhamad ^b   Pelloux, Sophie ^c   Riedinger, Jean Marc ^d   Frouin, Frédérique ^a   Tourneur, Yves ^c   Lizard, Gérard ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

7 ketocholesterol; Cardiomyocytes; Confocal microscopy; FAMIS; Iron nanoparticles; SYTOX Green

Indexed keywords

7 OXOCHOLESTEROL; DYE; HYDROETHYDINE; INTERLEUKIN 8; IRON NANOPARTICLE; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; SYTOX GREEN; TEXAS RED; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CHEMICAL LABELING; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FACTORIAL ANALYSIS; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HEART MUSCLE CELL; IMAGE PROCESSING; INFLAMMATION; MOUSE; NONHUMAN; OXIDATION;

MURINAE;

EID: 77951147584     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s8458     Document Type: Article

References (52)

1. Bruchez M, Moronne M, Gin, P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998; 281:2013-2016.
2. Taton T, Mirkin C, Letsinger R. Scanometric DNA array detection with nanoparticle probes. Science. 2000;289:1757-1760.
3. Cui Y, Wei Q, Park H, Lieber C. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science. 2001;293:1289-1292.
4. Colvin V. The potential environmental impacts of engineered nanomaterials. Nature Biotechnology. 2003;21:1166-1170.
5. Murthy SK. Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomedicine. 2007;2:129-141.
6. Weber WA, Czernin J, Phelps ME, Herschman HR. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Nat Clin Pract Oncol. 2008;5:44-54.
7. Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med. 2009;30:153-170.
8. Stroh A, Zimmer C, Gutzeit C, et al. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med. 2004;36:976-984.
9. Peters K, Unger RE, Gatti AM, Sabbioni E, Tsaryk R, Kirkpatrick CJ. Metallic nanoparticles exhibit paradoxical effects on oxidative stress and pro-inflammatory response in endothelial cells in vitro. Int J Immunopathol Pharmacol. 2007;20:685-695.
10. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19:975-983.
11. Tsuji JS, Maynard AD, Howard PC, et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci. 2006;89:42-50.
12. Oberdörster E. Manufactured nanomaterials (Fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environmental Health Perspectives. 2004;112:1058-1062.
13. Kolosnjaj J, Szwarc H, Moussa F. Toxicity studies of fullerenes and derivatives. Adv Exp Med Biol. 2007;620:168-180.
14. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839.
15. Kumar V, Farell G, Yu S, et al. Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell mediated calcification, and nanoparticles. J Investig Med. 2006; 54:412-424.
16. Tetley TD. Health effects of nanomaterials. Biochem Soc Trans. 2007;35(Pt 3):527-531.
17. Vejux A, Malvitte L, Lizard G. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res. 2008;41:545-556.
18. Lukyanenko V, Lukyanenko Y. Oxysterols in heart failure. Future Cardiol. 2009;5:343-354.
19. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006; 58:1471-1504.
20. Claycomb WC, Lanson NA, Stallworth BS, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocytes. Proc Natl Acad Sci USA. 1998; 95:2979-2984.
21. Pelloux S, Robillard J, Ferrera R, et al. Non-beating HL-1 cells for confocal microscopy: application to mitochondrial functions during cardiac preconditioning. Prog Biophys Mol Biol. 2006; 90:270-298.
22. Di Paola R, Bazin JP, Aubry F, et al. Handling of dynamic sequences in nuclear medecine. IEEE Trans Nucl Sci. 1982; 29:1310-1321.
23. Frouin F, Cinotti L, Benali H, et al. Extraction of functional volumes from medical dynamic volumetric datasets. Comp Med Imaging Graph. 1993;17:397-404.
24. Vejux A, Lizard G, Tourneur Y, Riedinger JM, Frouin F, Kahn E. Effects of caspase inhibitors (z-VAD-fmk, z-VDVAD-fmk) on Nile Red fluorescence pattern in 7-ketocholesterol-treated cells: investiga- tion by flow cytometry and spectral imaging microscopy. Cytometry A. 2007;71:550-562.
25. Kahn E. Confocal microscopy: characterization of fluorescent tracers by image processing of optical sections. Pathol Biol. 2001; 49:194-198.
26. Kawata S, Sasaki K, Minami S. Component analysis of spatial and spectral patterns in multispectral images I Basis. JOSA A. 1987; 4:2101-2106.
27. Lansing Taylor D, Waggoner AS, Murphy RF, Lanni F, Birge RR. Applications of Fluorescence in the Biomedical Sciences. New York: Alan R Liss Inc; 1986:129-140.
28. de la Monte SM, Neely TR, Cannon J, Wands JR. Ethanol impairs insulin-stimulated mitochondrial function in cerebellar granule neurons. Cell Mol Life Sci. 2001;58:1950-1960.
29. Cirelli N, Lebrun P, Gueuning C, et al. Secretory characteristics and viability of human term placental tissue after overnight cold preservation. Hum Reprod. 2000;15:756-761.
30. Prunet C, Montange T, Véjux A, et al. Multiplexed flow cytometric analyses of pro-and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A. 2006;69:359-373.
31. Lemaire-Ewing S, Prunet C, Montange T, et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol. 2005;91:97-114.
32. Moldrich RX, Beart PM, Pascoe CJ, Cheung NS. Low-affinity kainate receptor agonists induce insult-dependent apoptosis and necrosis in cultured murine cortical neurons. J Neurosci Res. 2000;59:788-796.
33. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol. 1990;47:440-448.
34. Rothe G, Valet G. Flow cytometric assays of oxidative burst activity in phagocytes. Methods Enzymol. 1994;233:539-548.
35. Kahn E, Frouin F, Souchier C, et al. Confocal multilaser focusing and single-laser characterization of UV excitable stains of cellular prepara- tions. Cytometry. 2000;40:42-49.
36. Kahn E, Lizard G, Pélégrini M, et al. Four-dimensional factor analysis of confocal images sequences (4D-FAMIS) to detect and characterize low numbers of human papillomavirus DNA by FISH in HeLa and SiHa cells. J Microscopy. 1999;193:227-243.
37. Harman HH. Modern Factor Analysis. Chicago: University of Chicago Press; 1960.
38. Benzecri JP. L'analyse des Données, Tome 2: L'analyse des Correspondances. Paris: Dunod; 1973.
39. Lizard G, Gueldry S, Sordet O, et al. Gluthatione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 1998; 12:1651-1663.
40. Bhatnagar A. Environmental cardiology. Studying mechanistic links between pollution and heart disease. Circ Res. 2006; 99:692-705.
41. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis. 1999;142:1-28.
42. Van Reyk DM, Brown AJ, Hult'en LM, Dean RT, Jessup W. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep. 2006;11:255-262.
43. Lemaire S, Lizard G, Monier S, et al. Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett. 1998;440:434-439.
44. Kahn E, Hotmar J, Frouin F, et al. Spectral and dynamic confocal fluorescence characterization of cytogenetic preparations by factor analysis. Anal Cell Pathol. 1996;12:45-56.
45. Kahn E, Receveur A, Coullin P, et al. Multiple excitation confocal analysis of targets in nuclei of cytogenetic preparations. Anal Quant Cytol Histol. 2004;26:1-7.
46. Kahn E, Vejux A, Menetrier F, et al. Analysis of CD36 expression on human monocytic cells and atherosclerotic tissue sections with quantum dots. Investigation by flow cytometry and spectral imaging microscopy. Anal Quant Cytol Histol. 2006;28:14-26.
47. Vejux A, Guyot S, Montange T, Riedinger JM, Kahn E, Lizard G. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J Nutr Biochem. 2009; 20:45-61.
48. Michalet X, Pinaud FF, Bentolila LA, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005;307:538-544.
49. Gao X, Dave SR. Quantum dots for cancer molecular imaging. Adv Exp Med Biol. 2007;620:57-73.
50. Royer MC, Lemaire-Ewing S, Desrumaux C, et al. 7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E: a specific role for alphatocopherol with consequences on cell death. J Biol Chem. 2009; 284:15826-15834.
51. Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomedicine. 2007;2:609-622.
52. Auffan M, Rose J, Bottero JY, Lowry GV, Jolivet JP, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol. 2009;4:634-641.